Abortion of myocardial infarction by primary angioplasty mainly depends on preprocedural TIMI flow

EuroIntervention

Volumn 6, Issue 7, 2011, Pages 854-859

  Birkemeyer, Ralf ^a   Rillig, Andreas ^a   Treusch, Fabian ^a   Koch, Annette ^a   Miljak, Tomislav ^a   Meyerfeldt, Udo ^a   Kunze, Markus ^a   Jung, Werner ^a   Höher, Martin ^b  

^a SCHWARZWALD BAAR KLINIKUM   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Aborted myocardial infarction; Preprocedural TIMI flow; Primary angioplasty

Indexed keywords

CREATINE KINASE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; ST SEGMENT ELEVATION; SURVIVAL TIME; THROMBOLYSIS MYOCARDIAL INFACRTION FLOW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT RESPONSE;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS;

EID: 79954512556     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I7A146     Document Type: Article

References (27)

1. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5. (Pubitemid 26308479)
2. Boersma E; The Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? A pooled analysis of randomised clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27:779-88.
3. Lamfers EJ, Hooghoudt TE, Uppelschoten A, Stolwijk PW, Verheugt FW. Effect of prehospital thrombolysis on aborting acute myocardial infarction. Am J Cardiol 1999;84:928-30. (Pubitemid 29475079)
4. Taher T, Fu Y, Wagner G, Goodman S, Fresco C, Granger C, Wallentin L, Van de Werf F, Verheugt F, Armstrong P. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001;358:605-13.
5. Rimar D, Crystal E, Battler A, Gottlieb S, Freimark D, Hod H, Boyko V, Mandelzweig L, Behar S, Leor J. Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction. Heart 2002;88:352-356.
6. Schroeder R, Wegscheider K, Schroeder K, Dissmann R, Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol 1995;26:1657-64.
7. Schroeder K, Wegscheider K, Zeymer U, Neuhaus KL, Schroeder R. Extent of ST-segment deviation in the single ECG lead of maximum deviation present 90 or 180 minuts after start of thrombolytic therapy best predicts outcome in acute myocardial infarction. Z Kardiol 2001;90:557-67. (Pubitemid 32778149)
8. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemmos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102:2031-7.
9. Miljak T, Birkemeyer R, Jung W. A 40-year-old female with headache and infarction ECG. Internist (Berl) 2007;48:1151-6. (Pubitemid 350045829)
10. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, Mattos L, Lansky AJ, O'Neill WW, Grines CL. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001;104:636-41. (Pubitemid 32738515)
11. Brodie BR, Stuckey TD, Hansen C, Muncy D. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol 2000;85:13-8. (Pubitemid 30045537)
12. De Luca G, Ernst N, Zijlstra F, van't Hof AWJ, Hoorntje JCA, Dambrink JHE, Gosslink ATM, de Boer MJ, Suryapranata H. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2004;43:1363-6.
13. Flameng W, Lesaffre E, Vanhaecke J. Determinants of infarct size in non-human primates. Bas Res Cardiol 1990;85:392-403. (Pubitemid 20275673)
14. Reimer KA, van der Heide RS, Ricard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 1993;72:13G-21G.
15. Garcia-Dorado D, Theroux P, Elizaga J, Galinanes M, Solares J, Riesgo M, Gomez MJ, Garcia-Dorado A, Fernandez Aviles F. Myocardial infarction in the pig heart model: infarct size and duration of coronary occlusion. Cardiovasc Res 1987;21:537-44. (Pubitemid 17106456)
16. Van't Hof A, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97:2302-6.
17. Henriques JP, Zijlstra F, Ottervanger JP, de Beer MJ, van't Hof AW, Hoorntje JC, Suryapranata H. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002;23:1112-7.
18. Grines CL, Serruys P, O'Neill WW. Fibrinolytic therapy: is ist a treatment of the past? Circulation 2003;107:2538-42.
19. Schömig A, Ndrepepa G, Mehilli J, Schwaiger M, Schühlen H, Nekolla S, Pache J, Martinoff S, Bollwein H, Kastrati A. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting ot thrombolysis. Circulation 2003;108:1084-8. (Pubitemid 37071518)
20. Zijlstra F, patel A, Jones M, Grines CL, Ellis S, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, Ribichini F, Granger C, Akhras F, Weaver WD, Simes RJ. Clinical characteristics and outcome of patients with early (<2h), intermediate (2-4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002;23:550-7.
21. Brodie BR, Stuckey TD, Wall TC, Kissling G, Hansen CJ, Muncy DB, Weintraub RA, Kelly TA. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998;32:1312-9. (Pubitemid 28522388)
22. Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, Gore JM, Weaver WD, Rogers WJ, Tiefenbrunn AJ. Relationship of symptom-onset-to-ballon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7. (Pubitemid 30414505)
23. Berger PB, Ellis SG, Holmes DR Jr, Granger CB, Criger DA, Betriu A, Topol EJ, Califf RM. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO-Iib) trial. Circulation 1999;100:14-20. (Pubitemid 29297934)
24. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic rewiev. Eur Heart J 2006;27:1523-29. (Pubitemid 43954909)
25. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitave review of 23 randomised trials. Lancet. 2003;361:13-20. (Pubitemid 36050955)
26. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O, Neunteufl T, Jorgova J, Dorobantu M, Grinfeld L, Armstrong P, Brodie BR, Herrmann HC, Montalescot G, Neumann FJ, Effron MB, Barnathan ES, Topol EJ; FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008;358:2205-17. (Pubitemid 351724450)
27. Stone GW, Ware JH, Bertrand ME, Lincoff AM, Moses JW, Ohmann EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, Pocock SJ; ACUITY Investigators. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one year result from the ACUITY trial. JAMA 2007;298:2497-506. (Pubitemid 350223536)